These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5114183)

  • 1. Concurrent session: drug metabolism and the liver.
    Med J Aust; 1971 Sep; 2(12):Suppl 3:21-2. PubMed ID: 5114183
    [No Abstract]   [Full Text] [Related]  

  • 2. Major drug interactions: effect of liver disease, alcohol, and malnutrition.
    Hoyumpa AM; Schenker S
    Annu Rev Med; 1982; 33():113-49. PubMed ID: 7044269
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug catabolism and its significance for pharmacotherapy].
    Kolenda KD
    Med Klin; 1980 Mar; 75(7):240-50. PubMed ID: 6771507
    [No Abstract]   [Full Text] [Related]  

  • 4. Dr. Henry Baker Lecture Interaction of ethanol with drug toxicity.
    Lieber CS
    Am J Gastroenterol; 1980 Oct; 74(4):313-20. PubMed ID: 7457455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive treatment in liver diseases].
    Ritland S
    Tidsskr Nor Laegeforen; 1983 Apr; 103(10):839-40. PubMed ID: 6879519
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of methionine in liver disease.
    Mato JM; Ortiz P
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():35-46. PubMed ID: 8899692
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescribing for patients with liver damage.
    Drug Ther Bull; 1970 Nov; 8(24):93-4. PubMed ID: 5491958
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive therapy in liver diseases].
    Pelikán V; Seidlová V
    Cesk Gastroenterol Vyz; 1971 Oct; 25(7):321-2. PubMed ID: 5119853
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug-induced liver reactions as therapeutic principle].
    Gladtke E
    Monatsschr Kinderheilkd (1902); 1979 Mar; 127(3):122-4. PubMed ID: 423900
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological changes during the treatment of chronic liver diseases with immunosuppressive agents].
    Zivković R; Babić D; Radosević V; Sket-Janković N; Bogdan I; Vercko K; Varlaj V
    Acta Med Iugosl; 1976; 30(5):497-508. PubMed ID: 1015350
    [No Abstract]   [Full Text] [Related]  

  • 11. [The clinical pharmacology and efficacy of Essentiale in liver diseases].
    Skakun NP
    Eksp Klin Farmakol; 1993; 56(1):69-72. PubMed ID: 8324485
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclosporin in the treatment of chronic diseases of the liver (excluding transplantation)].
    Di Martino V; Cadranel JF; Erlinger S
    Gastroenterol Clin Biol; 1997; 21(5):400-11. PubMed ID: 9208017
    [No Abstract]   [Full Text] [Related]  

  • 14. [For which liver diseases is immunosuppressive therapy indicated?].
    Bannaski H
    Med Klin Prax; 1982 Aug; 77(16-17):66-71, 74. PubMed ID: 7132889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-drug interactions with immunosuppressive agents: review of the in vitro functional assays and role of cytochrome P450 enzymes.
    Elbarbry FA; Marfleet T; Shoker AS
    Transplantation; 2008 May; 85(9):1222-9. PubMed ID: 18475175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Corticosteroids and the liver. Metabolism and indications in liver diseases].
    Uribe M; Ramos MH
    Rev Invest Clin; 1983; 35(1):71-80. PubMed ID: 6346450
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy in liver disease].
    Jorup-Rönström C
    Lakartidningen; 1982 Apr; 79(14):1367-9. PubMed ID: 7087612
    [No Abstract]   [Full Text] [Related]  

  • 18. Variability in human drug metabolism and its implications.
    Breimer DD
    Int J Clin Pharmacol Res; 1983; 3(6):399-413. PubMed ID: 6381339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liver, protein metabolism and branched-chain amino acids].
    Bernardi R
    Clin Ter; 1981 Dec; 99(6):653-75. PubMed ID: 7037278
    [No Abstract]   [Full Text] [Related]  

  • 20. CYP1A2 and 2E1 expression in rat liver treated with combined inducers (3-methylcholanthrene and ethanol).
    Goasduff T; Menez JF; Dreano Y; Berthou F
    Biochem Biophys Res Commun; 1995 Jun; 211(2):497-503. PubMed ID: 7794261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.